RTN4 and myeloid sarcoma: Furthermore, analyses of demyelinating lesions in MS patients demonstrated that RTN4A is highly expressed in oligodendrocytes, while its NgR receptor appears specifically in reactive astrocytes and microglia/macrophages (Satoh et al. 2005).